Notices for Week of: OCTOBER 06, 2005
PROPOSED STATE RULES
By law, public notice of proposed rules must be given by publication in newspapers of record. The purpose of these notices is to give the public a chance to respond to the proposals. The public notices for administrative rules are now also available online at http://vermont-archives.org/aparules/ovnotices.htm The law requires an agency to hold a public hearing on a proposed rule, if requested to do so in writing by 25 persons or an association having at least 25 members.
To make special arrangements for individuals with disabilities or special needs please call or write the contact person listed below as soon as possible
To obtain further information concerning any scheduled hearing(s), obtain copies of proposed rule(s) or submit comments regarding proposed rule(s), please call or write the contact person listed below. You may also submit comments in writing to the Legislative Committee on Administrative Rules, State House, Montpelier, Vermont 05602 (828-2231).
Regulated Drug Rules
Vermont Proposed Rule: 05P048
AGENCY: Human Services, Department of Health
CONCISE SUMMARY: Adds buprenorphine to the Regulated Drugs Rule, thus making the unlawful possession and distribution of buprenorphine a State crime. Buprenorphine is an opioid partial agonist which was approved by the Food and Drug Administration (FDA) for the use in opioid addiction treatment in October, 2002. Because of its opioid agonist effects, buprenorphine is abusable, particularly by individuals who are not physically addicted to opioids. Unlawful possession and distribution of buprenorphine is a Federal crime.
TYPE OF PERSONS AFFECTED: Law enforcement entities such as State's Attorneys and police officers, District Courts, criminal defense attorneys, and the Defender General's Office are potentially affected. Vermont State's Attorney's Offices have reported a couple of occasions in which individuals have possessed buprenorphine without having received a prescription for the drug. They cannot currently prosecute under State law.
COST BENEFIT ANALYSIS: Vermont State's Attorney's Offices have reported a couple of occasions in which individuals have possessed buprenorphine without having received a prescription for the drug. Since the number of occasions has been small, the economic impact of adding buprenorphine to the Regulated Drugs Rule is expected to be insignificant.
SCHEDULED HEARINGS: October 24, 2005, 4 P.M. ; Department of Health, 108 Cherry Street, Room 3B, Burlington, VT 05401
DEADLINE FOR PUBLIC COMMENT: November 2, 2005
FOR FURTHER INFORMATION, CONTACT: William E. Wargo, Department of Health, PO Box 70, Burlington, VT 05402-0070 (802)863-7281
Return to the 2005 date selection page for more weekly notices or choose from the links in the left sidebar for notices from a different year.
*****************************************
- If you have general questions about the rulemaking process, please contact
- Louise Corliss by e-mail at or by phone 802-828-2863
